Sign in
SC 13D

Beneficial Ownership Report

Eloxx Pharmaceuticals, Inc. Filed Acc 0001015357-99-000066

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2024-08-20 SC 13D/A · Advent Life Sciences LLP 3.98%
  2. 2023-02-13 SC 13G/A · Roche Finance Ltd 0.1%
  3. 2022-02-14 SC 13G/A · Roche Finance Ltd 5.8%
  4. 2022-02-03 SC 13D/A · LSP V Coöperatieve U.A 3.4%
  5. 2021-06-29 SC 13G · Gurnet Point L.P. 5.7%
  6. 2021-06-14 SC 13G · Roche Finance Ltd 5.3%
  7. 2021-05-21 SC 13D/A · Pontifax Management 4 G.P. (2015) Ltd. 8.66%
EDGAR lists no main document for this filing. Open it on SEC EDGAR (opens in new tab)